Omaha, NE, United States of America

Yan Liu

This inventor holds 6 USPTO granted patents. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., Chongqing Zein Pharmaceutical Co., Ltd, The Board of Regents of the University of Nebraska. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Liu. Retrieved from https://idiyas.com/inventor/yan-liu-6q6w955f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tampa, FL (US) (2016)
  • Omaha, NE (US) (2017 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yan Liu: Innovator in Pyrrolomycin Research

Introduction

Yan Liu is a prominent inventor based in Omaha, NE (US), known for his significant contributions to the field of medicinal chemistry. With a total of 6 patents, Liu has focused on developing innovative solutions to combat infectious diseases and cancers.

Latest Patents

Among his latest patents, Liu has developed pyrrolomycin derivatives that can modulate Mcl-1, inhibit the proliferation of bacteria and pathogens, and provide therapeutic options for treating various infectious diseases and cancers. These advancements highlight his commitment to addressing critical health challenges through innovative research.

Career Highlights

Liu has worked with esteemed organizations such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and Chongqing Zein Pharmaceutical Co., Ltd. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Rongshi Li and Said M Sebti, who have played essential roles in his research endeavors.

Conclusion

Yan Liu's innovative work in pyrrolomycin research exemplifies his dedication to advancing medical science. His contributions are paving the way for new treatments that could significantly impact public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…